header
December 18, 2017

In This Issue
IN THE SPOTLIGHT
Opioid Task Force Issues Final Report
Opportunities for Year-End Giving at MMA
Maine Falls to #23 in America's Health Rankings
Online Links to Opioid CME
8 in 10 Doctors Have Experienced a Cyber Attack in Practice
Naloxone Research Shows Importance of Post-Administration Intervention
AMA Statement on Proposed Aetna-CVS Merger
Peer Navigation Program from Facing Our Risk of Cancer Empowered
128TH MAINE LEGISLATURE
Legislative Calls to Resume When Legislature Returns
Highlights of Recently Enacted Legislation: L.D. 593 (c. 63) Medical License Renewal
UPCOMING EVENTS
Online Learning Opportunities Offering CME Credits - from the Northern New England Practice Transformation Network
New Free CME on Alzheimer's Risk, Detection, and Management
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Chief Executive Officer - Pines Health Services
Clinical Cardiology Opportunity
Primary Care Physician - Eastern Maine Medical Center
Relocate to Beautiful Southwestern Maine - Medical Director/Family Practice Physician
Palliative Care Provider
Gastroenterologist - Brunswick, ME
Hospitalist - Brunswick, ME
DO or MD Physician - Augusta, ME
Outpatient Only - Internal Medicine with Loan Repayment & Sign-on Bonus
Physiatrist - Brunswick, Maine
Opportunities at the VA for Volunteer Physicians

 
Search Back Issues





 



Follow Us:
Naloxone Research Shows Importance of Post-Administration Intervention

More than 84 percent of Massachusetts patients who received naloxone from emergency medical services were alive one year following the administration. The study abstract, published in the Annals of Emergency Medicine, reviewed data from more than 12,000 naloxone administrations between July, 1, 2013, and Dec. 31, 2015. The study's authors concluded that, among other things: "Patients who survive opioid overdose should be considered extremely high risk and should receive interventions such as offering buprenorphine, counseling and referral to treatment prior to [emergency department] discharge."

Read more about naloxone on the AMA opioid microsite.
 

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©